Group News

What's New in the Department of Surgery

Novilase Trial Enrolling Now

Laser therapy to treat early stage breast cancer. Columbia University Medical Center is now enrolling patients in a new clinical trial examining the effectiveness of laser therapy to treat early-stage breast cancer. This new research is testing a non-surgical treatment called Novilase® Interstitial Laser Therapy (ILT). The study will test the ability of the laser to ablate (destroy) breast cancers that are equal to or less than 2 centimeters in size. Approximately 50% of breast cancer patients are estimated to qualify for inclusion in the study. Traditionally, early-stage breast cancers have been removed by surgery, i.e., lumpectomy, which can unfavorably affect the look and feel of the breast. Destroying the tumor with a laser may have advantages including: Minimal scarring, Less chance of infection, Much shorter recovery time, Preservation of natural shape (i.e., cosmetic appearance) and feel of the breast
Read More >
Researchers at Columbia University Medical Center have discovered that certain women undergoing radiation therapy for early-stage breast cancer may have an elevated risk of developing cardiovascular disease.
Read More >
Blog & Newsletter

Are You Dense?

Dr. Elise Desperito, a breast radiologist at NYP/Columbia's Clinical Breast Cancer Program, discusses the importance of breast density in the detection and treatment of breast cancer.
Read More >
What's New in the Department of Surgery

Study on Genetics and Breast Cancer in Asian Women

Read More >

Pages